Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. - Wikidata - awgldk - TriplyDB

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

http://www.wikidata.org/entity/Q33343390

about

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Successful Treatment of Leukemic Mature B-Cell Lymphoid Neoplasm with Similar Features to Splenic Marginal Zone Lymphoma Possessing Aberrant Myeloid Markers.Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.Paraneoplastic Syndrome in Splenic Marginal Zone Lymphoma: A Rare Phenomenon of Paraplegia as an Atypical Presenting Manifestation Epidemiology, pathology and treatment of non-follicular indolent lymphomas.Splenic marginal lymphoma and glomerulonephritis: case report and review of the literature.Development of autoimmunity in lymphoma.Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study.A rare case of splenic marginal zone B-cell lymphoma mimicking relapsing polychondritis of the ear.Rituximab in the treatment of non-Hodgkin's lymphoma Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.[Splenic marginal zone lymphoma].Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.Unusual Course of Splenic Marginal Zone Lymphoma.Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.Surgical management of splenic marginal zone lymphoma.Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.

P2860

Q33800449-48CA12E3-5657-4829-912D-F8F15823DC44 Q36199218-E65208DE-2B95-4310-96D0-DC19B3161D3B Q36630461-D5A57919-3009-4652-B6A2-B851513004E5 Q36932991-4D28FF99-7DED-4FDA-9252-3E2ABD776832 Q37280928-100656D9-4AB2-47BA-8F42-3174CBFCADDD Q37701856-6BEE5D6E-E0FA-4C35-AA6B-7FBDDE690454 Q37754707-E5E26A59-1E2A-4BB7-A430-09A464454BAA Q38139569-28A83806-FE51-4F26-9962-29DDFED8F7FB Q39347902-D785B021-9D1F-47DA-A306-32E913C8C58A Q41407104-1725B14D-5C33-43B6-9E7D-CF0C942EB0B9 Q41578832-67663B86-FF3E-4770-A5EB-5140329E68F2 Q41925899-B5FC3B4B-F3CF-475C-BBAB-A659BAF772A0 Q42256967-A8C749D7-B6B5-4E70-82AE-5DEA757C1CC6 Q42271461-BF4A666F-7BF5-42D1-BF40-12A68836DEBA Q44223923-75B67256-855E-405F-89E8-BE2F8FB690D8 Q45124918-C6F30F46-C68A-4F27-8C1A-AE6194594643 Q47123855-7305C59B-C2CE-45AA-B7C4-5249D0778EAB Q47153921-1C99D8BC-6C9B-4539-A523-52E0AA71FB71 Q47219319-FDB20B06-6205-4FDB-8D96-33BD3EF25566 Q47771527-9224D81E-41E1-491E-AF39-4E407185CB4C Q48331134-25602BBE-91A1-48ED-AC4A-D3385A8E7803 Q52599792-35B3C8C6-9974-4514-B8B2-05EE9998DE66 Q52916837-5EA864BB-7F42-4C7F-9095-2DF85B8296DD

P2860

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

http://www.wikidata.org/entity/Q33343390

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@ast

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@en

type

label

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@ast

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@en

prefLabel

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@ast

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@en

P1433

Q33343390-FFE11787-8ABF-42D5-A581-EEDDE8FCF806

P1476

Q33343390-90BB79E9-FAE6-48A9-BF71-2E768C027DD7

P2093

Q33343390-078C4FE9-B1AE-474B-84DB-6B645EEB91ED

Q33343390-40067D94-5E45-42BF-9895-FD06B7C32980

Q33343390-6FB3683D-4D7C-48BF-BFCF-CD57810FEFC5

Q33343390-872B8DA1-5561-4763-8EF0-04875223B4B5

Q33343390-98C120BB-7D33-4AEC-8DB3-72CBADE4CD2D

Q33343390-9D1F7723-C0F4-475F-847A-EDE4D9461BB9

Q33343390-C99A7645-7329-4E9F-8FCB-2D2FFAB79016

Q33343390-CF92ECCD-FE68-4C6D-8487-3A7396118F4C

Q33343390-F6A10494-93F0-4DA3-90BE-040C7C3FDBE5

Q33343390-F8D7C393-60EC-4497-805B-8D32C083610F

P304

Q33343390-2E3B3273-AD69-4D4D-A85F-299C0C11DF73

P31

Q33343390-1D1B48D4-E30C-449C-B684-8E2ABC6ACDE8

P356

Q33343390-98507083-8554-4CB4-BA7B-A1EFE12F326F

P433

Q33343390-C6DC971B-A452-48A1-8CFD-D1408B6001E1

P478

Q33343390-B42503D1-61D6-417C-8B36-C63F4DBE1F47

P50

Q33343390-56D42913-AFC6-4631-A704-C480347E68B8

Q33343390-B0439E06-175B-4A57-B4AB-1CD78FE74A50

P577

Q33343390-DA36274B-3448-4E0D-B344-0F2BF4F7C4F3

P698

Q33343390-847D963C-8368-46B2-868B-31C99632EB4B

P356

P1433

Clinical Lymphoma and Myeloma

P1476

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

@en

P2093

Bertrand Coiffier

http://www.w3.org/2001/XMLSchema#string

Catherine Thieblemont

http://www.w3.org/2001/XMLSchema#string

Charles Dumontet

http://www.w3.org/2001/XMLSchema#string

Evelyne Callet-Bauchu

http://www.w3.org/2001/XMLSchema#string

Francoise Berger

http://www.w3.org/2001/XMLSchema#string

Gilles Salles

http://www.w3.org/2001/XMLSchema#string

Josette Arcache

http://www.w3.org/2001/XMLSchema#string

Olivier Hequet

http://www.w3.org/2001/XMLSchema#string

Pascale Felman

http://www.w3.org/2001/XMLSchema#string

Philippe Arnaud

http://www.w3.org/2001/XMLSchema#string

P304

41-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3816/CLM.2002.N.010

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Thieblemont

Evelyne Callet-Bauchu

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12141954

http://www.w3.org/2001/XMLSchema#string